AzTrials
AzTrials

Chronic Obstructive Pulmonary DiseaseNCT05984498

Understanding Balance Impairment in COPD

An observational study of Chronic Obstructive Pulmonary Disease and Healthy Volunteers, run by Teesside University at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is an observational study investigating the mechanisms of balance problems in people with COPD and how COPD impacts them living their daily lives. The main objectives of this study are: To quantify the relationship between balance and aspects of neuromuscular function in individuals with COPD, and compared… Read more about this study

Who is it for?
Ages 55 years and olderHealthy volunteers can take part
How many people
40 participants
Where
1 siteUnited Kingdom
Study dates
17 Jul 2023to 1 May 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 55 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: People living with COPD and people without COPD living in community settings in the North East of England, UK

Who may be able to join

  • COPD
  • Have a spirometry confirmed diagnosis of COPD as per GOLD guidelines
  • Stable COPD (six weeks clear of exacerbation)
  • 55 years or over at the point of recruitment
  • Able to communicate with good verbal English or use adaptive equipment to communicate
  • Male or female Controls
Show all 11Show fewer
  • Free from a diagnosis of COPD (confirmed by spirometry)
  • 55 years or over at the point of recruitment
  • Able to communicate with good verbal English or use adaptive equipment to
  • Communicate
  • Male or female

Who cannot join

  • COPD
  • Recent exacerbation of COPD (within the last six weeks)
  • Under 55 years of age at the point of recruitment
  • Any neurological or musculoskeletal diagnoses (e.g., strokes, Parkinson's disease or chronic pain that interferes with ability to safely complete the tests
  • Unable to provide written informed consent
  • Unable to speak English or no translation options available
Show all 17Show fewer
  • Diagnosed but not corrected visual, vestibular disturbance and peripheral neuropathy
  • Vasovagal syncope
  • Not independent living (e.g., living in a care home or prison) Controls
  • Abnormal lung function (FEV1 and FVC equal to or greater than 80% and FEV1/FVC equal to greater than 70%)
  • Under 55 years of age at the point of recruitment
  • Any neurological or musculoskeletal impairment that would significantly affect balance impacting ability to safely complete the assessments
  • Unable to provide written informed consent
  • Unable to speak English or no translation options available
  • Any uncorrected visual or somatosensory disturbance
  • Vasovagal syncope
  • Living in a care home or in prison

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Teesside University

    Middlesbrough, TS1 3BX

Other trials in United Kingdom

About this study

Official title: An Investigation of the Physiological and Psychosocial Mechanisms Underpinning Balance Impairment in People With Chronic Obstructive Pulmonary Disease

This study is an observational study investigating the mechanisms of balance problems in people with COPD and how COPD impacts them living their daily lives.

The main objectives of this study are:

Read more
  • To quantify the relationship between balance and aspects of neuromuscular function in individuals with COPD, and compared to age-matched healthy controls
  • To understand the lived experience of people with COPD and their carers

Participants will attend an appointment at the University rehab lab to:

  • Complete a balance test
  • Fill out some questionnaires on mood, health status and balance and falls
  • Complete some walking tests
  • Have their body composition measured
  • Have the function and strength of their leg nerves and muscles tested Researchers will compare people with COPD and healthy controls (older adults without COPD or other conditions known to impact balance) to see if any of the things measured are impacting the balance of people with COPD more than their peers without COPD.
  • For 10 people with COPD only they will be visited at home to observe how they carry out everyday tasks and 5 of those 10 will have a follow up interview.

Researchers will take notes and record interviews and look for similarities and interesting points in the notes and transcripts of the interviews to build a picture of what living with COPD is like.

Read the detailed description

Chronic obstructive pulmonary disease (COPD) is a progressive condition that affects around 1.2million people in the UK. Breathlessness is the main symptom but people with COPD are also more likely to fall than healthy people of the same age. Falling has emotional consequences, such as feelings of shame, embarrassment and fear of falling in public which leads to avoidance of outdoor activities. Researchers do not know why people with COPD fall more but they have poor balance which may, in part, be due to problems with sensory and muscle responses that would usually maintain balance. Symptoms of breathlessness and pain, plus inactivity, may further impact balance. Physical and social environments may also have a role in falls risk, but this has yet to be investigated. Pulmonary Rehabilitation (PR) which includes stamina and strength exercises, alongside education and emotional support is standard treatment for COPD but it does not include any balance exercises, meaning people with COPD who are at a greater risk of falling do not receive any routine treatment to improve balance. This study aims to investigate the physical, psychological, social and environmental factors impacting on balance in people with COPD by comparing them to older adults without COPD. The study will recruit from local hospital services (people with COPD and their carers without COPD) and within the community (healthy older adults). Balance, muscle function (size, strength and speed of nerve conduction) and physical activity will be measured, and the two groups compared. Researchers will also observe patients in their own homes and do follow up interviews to understand what it is like to live with COPD and the challenges people face. The information from this study will be used in conjunction with stakeholders to co design an intervention to improve balance in people with COPD.

Keywords
Chronic, Obstructive Pulmonary Disease, Balance, Falls, Nerve Function, Muscle Function, Lived Experience
Medical subject headings
Pulmonary Disease, Chronic Obstructive

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT05984498
Study groupRoleWhat they receive
COPD groupPeople with a spirometry confirmed diagnosis of Chronic Obstructive Pulmonary Disease (COPD)
Healthy ControlsOlder adults over the age of 55 who do not have COPD

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Balance Evaluation Systems Test (BESTest)

    27 functional tasks scored on a 0-3 scale to give an overall percentage out from a maximum of 108 points. Higher scores indicate better balance.

    Measured: baseline only

Secondary outcomes (17)
  1. The Activities- Specific Balance Confidence Scale (ABC)

    A questionnaire that assesses confidence for performing 16 activities without a loss of balance. Scores for each item range between 0 (not confident) and 100% (completely confident). The total score for each item is divided by the number of items (16).

    Measured: baseline only

  2. The Elderly Falls Screening Test

    A questionnaire and test that involves three questions relating to falls history in the previous 12-months and a gait speed and pattern assessment over a 5-meter course to establish falls risk. Score out of 5 with higher scores indicating a greater risk of falls.

    Measured: baseline only

  3. Incremental Shuttle Walk Test

    A walking test where participants walk between two cones that are 10 meters apart to a increasingly frequent paced beep to measure exercise capacity. The diatnace walked is reported to the nearest 10m.

    Measured: baseline only

  4. COPD Assessment Test

    A questionnaire measuring COPD health related quality of life. Scored between 0 and 40 with higher scores indicating the greatest impact of COPD on quality of life.

    Measured: baseline only

  5. Medical Research Council Dyspnoea Scale

    A one question scale (0-4) of the impact of breathlessness with higher scores indicating greater impact of symptoms.

    Measured: baseline only

  6. Lung function testing (spirometry) Forced expiratory volume in one second (FEV1) and FEV1/forced vital capacity (FEV1/FVC)

    A measure of lung function used to define COPD. Participants blow into a handheld spirometry device. FEV1 and FEV1 / FVC will be recorded.

    Measured: baseline only

  7. Patient Health Questionnaire-9 (depression)

    A one page questionnaire that measures symptoms of depression and low mood. Scored out of 27 with higher scores indicated greater symptoms of depression.

    Measured: baseline only

  8. Generalised Anxiety Disorder-7 Questionnaire (anxiety)

    A one page questionnaire that measures symptoms of anxiety. Scored out of 21 with higher scores indicating worse symptoms of depression.

    Measured: baseline only

  9. Brief Pain Inventory

    A two page questionnaire that records pain, pain intensity, pain location and pain interference. It consists of 9 items which are rated 0-10 with higher scores indicating a greater severity of pain.

    Measured: baseline only

  10. Somatosensory accuracy

    Vibration sensation perception will be measured with a neurothesiometer device on both big toes.

    Measured: baseline only

  11. Maximal Voluntary Contraction Strength

    The maximal strength that participants can generate in their thigh and calf muscles will be measured with a biodex dynamometer

    Measured: baseline only

  12. Voluntary Activation Test

    The amount of muscle available on top of a voluntary contraction in the quadriceps muscle will be measured using the biodex dynamometer and an electrical stimulus over the thigh muscles (Interpolated Twitch Technique)

    Measured: baseline only

  13. Hoffman's Reflex

    The speed and size of nerve response to a stimulus that mimics balance reactions will be measured in the tibial nerve by placing a small bar over the back of the knee that gives an electrical stimulus to the nerve.

    Measured: baseline only

  14. Maximum grip strength

    Participants hold a handheld dynamometer in their hands and squeeze the device to measure grip strength.

    Measured: baseline only

  15. Physical Activity Monitor

    Participants will be asked to wear a watch sized device (Actigraph Physical Activity Monitor) on their wrists for 7 days. The actigraph device measures levels of physical activity

    Measured: baseline through to 7 days

  16. EuroQOL-5D-5Level

    The EQ-5D-5L descriptive system comprises five dimensions (MOBILITY, SELF-CARE, USUAL ACTIVITIES, PAIN /DISCOMFORT and ANXIETY / DEPRESSION) and each dimension has five response levels (no problems to unable/severe problems). Responses form a 5 digit code.

    no problems, slight problems, moderate problems, severe problems, unable to /extreme problems.

    Measured: baseline only

  17. Bioelectrical impendence analysis to record whole body composition of muscle, bone and fat

    A bioelectrical impedance device (Tanita BIA) will record measures of body composition

    Measured: baseline only

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Aug 2023
  2. Study start17 Jul 2023
  3. Primary completion1 May 2024
  4. Study completion1 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05984498
Sponsor's protocol ID
2022 Aug 10959 Harrison
Other IDs
NIHR300856
Status last verified
Oct 2026
First submitted
21 Jul 2023
Last updated
5 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Chronic Obstructive Pulmonary Disease and Healthy Volunteers, run by Teesside University at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Balance Evaluation Systems Test (BESTest) (time frame: baseline only). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Understanding Balance Impairment in COPD (NCT05984498) | AzTrials